Vaxxinity Statistics
Share Statistics
Vaxxinity has 126.78M
shares outstanding. The number of shares has increased by 0%
in one year.
| Shares Outstanding | 126.78M |
| Shares Change (YoY) | 0% |
| Shares Change (QoQ) | 0% |
| Owned by Institutions (%) | 0.21% |
| Shares Floating | n/a |
| Failed to Deliver (FTD) Shares | n/a |
| FTD / Avg. Volume | n/a |
Short Selling Information
The latest short interest is 4.22M, so undefined% of the outstanding
shares have been sold short.
| Short Interest | 4.22M |
| Short % of Shares Out | n/a |
| Short % of Float | 7.59% |
| Short Ratio (days to cover) | 13.97 |
Valuation Ratios
The PE ratio is -1.89 and the forward
PE ratio is null.
Vaxxinity's PEG ratio is
0.08.
| PE Ratio | -1.89 |
| Forward PE | n/a |
| PS Ratio | 0 |
| Forward PS | n/a |
| PB Ratio | 0.01 |
| P/FCF Ratio | 0 |
| PEG Ratio | 0.08 |
Financial Ratio HistoryEnterprise Valuation
Currently the Enterprise Value (EV) is not available for Vaxxinity.
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.89,
with a Debt / Equity ratio of 1.13.
| Current Ratio | 1.89 |
| Quick Ratio | 1.89 |
| Debt / Equity | 1.13 |
| Debt / EBITDA | -270.61 |
| Debt / FCF | -0.26 |
| Interest Coverage | -83.74 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
| Return on Equity | n/a |
| Return on Assets | n/a |
| Return on Invested Capital | n/a |
| Revenue Per Employee | n/a |
| Profits Per Employee | $-998.84 |
| Employee Count | 57 |
| Asset Turnover | 0 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -56.93K |
| Effective Tax Rate | 100% |
Stock Price Statistics
The stock price has increased by null% in the
last 52 weeks. The beta is 1.07, so Vaxxinity's
price volatility has been higher than the market average.
| Beta | 1.07 |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | 0.01 |
| 200-Day Moving Average | 0.04 |
| Relative Strength Index (RSI) | 47.47 |
| Average Volume (20 Days) | n/a |
Income Statement
| Revenue | n/a |
| Gross Profit | -2.23M |
| Operating Income | -58.28M |
| Net Income | -56.93K |
| EBITDA | -56.05K |
| EBIT | 639.07K |
| Earnings Per Share (EPS) | -0.45 |
Full Income StatementBalance Sheet
The company has 5.04M in cash and 15.17M in
debt, giving a net cash position of -10.13M.
| Cash & Cash Equivalents | 5.04M |
| Total Debt | 15.17M |
| Net Cash | -10.13M |
| Retained Earnings | -361.64M |
| Total Assets | 44.31M |
| Working Capital | 15.63M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -57.24M
and capital expenditures -803K, giving a free cash flow of -58.04M.
| Operating Cash Flow | -57.24M |
| Capital Expenditures | -803K |
| Free Cash Flow | -58.04M |
| FCF Per Share | -458.79 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
